𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pilot study of escalating doses of carboplatin and cyclophosphamide in patients with advanced cancer

✍ Scribed by Russell L. Basser; Michael D. Green; William P. Sheridan; Richard M. Fox

Publisher
Springer
Year
1992
Tongue
English
Weight
273 KB
Volume
30
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dose escalation study of tezacitabine in
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer
✍ Keith T. Flaherty; James P. Stevenson; Maryann Gallagher; Bruce Giantonio; Kenne πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The authors performed a dose escalation study of cisplatin and the novel deoxycytidine analog, tezacitabine, to determine the maximum tolerated dose of the combination. ## METHODS Twenty‐three patients with advanced cancer and good performance status were accrued to 3 d

Dose escalation study of carboplatin wit
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan
✍ Nobuyuki Katakami; Minoru Takada; Shunichi Negoro; Katsuyasu Ota; Jiro Fujita; K πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 738 KB

## BACKGROUND. We performed a Phase 1-11 trial to determine the maximum tolerated dose of carboplatin (CBDCA) with a fixed dose of VP-16 and granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC) patients. ## METHODS. Treatment consisted of a starting dose of CBDCA, 400